Revolutions Medical receives 510K FDA clearance to market Rev Vac safety syringe

Revolutions Medical Corporation has received notification from the FDA that the 510K application for the Rev Vac safety syringe is approved. This represents a major step forward for the company towards realizing its goal in becoming a major player in the safety syringe market.

The Rev Vac safety syringe uses patented technology to draw the needle back into the syringe chamber after use. This safety syringe should result in a decrease in accidental needle stick injuries. Another important safety feature is that it will disallow the reuse of the syringe. This may significantly decrease the spread of HIV and other blood borne diseases. This safety syringe takes only one hand to use, which is a very important feature for the health care practitioner or medical personnel. There are no clumsy clamps, sheaths or other complex safety features that require two handed use.

“We are pleased to receive 510K FDA clearance for our Rev Vac safety syringe. I
want to congratulate all of our patient, loyal shareholders. This important step forward will enable the company to aggressively pursue its goal of getting this important safety syringe into the marketplace. Our Rev Vac safety syringe has significant advantages over our competitors and we expect a warm reception from the medical industry,” states Ron Wheet, CEO of Revolutions Medical Corporation.

Rich Theriault, President of Strategic Product Development (SPD) states, “This
is a key milestone as we can now move forward with the manufacturing and sales
of the Rev Vac product line. As the company transitions from strictly Research
and Development of a number of proprietary technologies into sales and
marketing, we expect to release a series of products into the medical
marketplace over the next two years.”

About Revolutions Medical Corporation
Revolutions Medical Corporation is committed to continually developing and
distributing new products and tools to the medical industry, whether internally
or through acquisitions. Its goals are to make health care safer and less
expensive by reducing risks and cutting time and expenses. Its products include
the Rev Vac safety syringe, safety blood drawing device and safety IV catheter.
The world market for safety-engineered medical devices (SEMDs) is projected to
exceed 2 billion this year and is forecasted to maintain a 20% annual growth
rate in the near term. Revolutions Medical also provides software solutions and
proprietary tools that are compatible with standard MRIs and standard PACS. The
software includes sorting of images, color, 3D, and automatic segmentation of
images. These tools will enhance the physician`s diagnostic confidence in an
industry that is growing at 10% – 15% (more than 25 million procedures) per year with a worldwide market potential for these tools that exceeds $3.5 billion.